HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ning Huang Selected Research

L-Lactate Dehydrogenase (Lactate Dehydrogenase)

11/2018The role of RIP3 in cardiomyocyte necrosis induced by mitochondrial damage of myocardial ischemia-reperfusion.
10/2012Combination of hypoxic preconditioning and postconditioning does not induce additive protection of ex vivo human skeletal muscle from hypoxia/reoxygenation injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ning Huang Research Topics

Disease

51Neoplasms (Cancer)
04/2024 - 01/2008
22Infections
11/2022 - 10/2003
18Glioma (Gliomas)
03/2024 - 11/2013
12Hepatocellular Carcinoma (Hepatoma)
11/2023 - 02/2009
12Hypoxia (Hypoxemia)
05/2023 - 07/2003
11Inflammation (Inflammations)
07/2023 - 10/2006
10Ischemia
10/2022 - 03/2004
6Carcinoma (Carcinomatosis)
09/2023 - 01/2011
6Necrosis
11/2020 - 03/2003
6Reperfusion Injury
01/2020 - 02/2005
5Atherosclerosis
01/2024 - 06/2005
5Breast Neoplasms (Breast Cancer)
12/2023 - 04/2008
5Obesity
07/2023 - 09/2014
5Infarction (Infarctions)
03/2013 - 02/2005
4Cognitive Dysfunction
11/2023 - 01/2021
4Body Weight (Weight, Body)
01/2023 - 09/2016
4Colonic Neoplasms (Colon Cancer)
01/2015 - 01/2011
3Periodontitis
05/2024 - 01/2021
3Glioblastoma (Glioblastoma Multiforme)
12/2023 - 01/2021
3Cholangiocarcinoma
10/2023 - 05/2022
3Fibrosis (Cirrhosis)
03/2023 - 11/2015
3Pituitary Neoplasms (Pituitary Adenoma)
01/2023 - 08/2020
3Colitis
12/2022 - 03/2016
3Melanoma (Melanoma, Malignant)
01/2022 - 05/2014
3Cleft Lip (Harelip)
01/2022 - 08/2011
3Vascular Remodeling
11/2021 - 12/2019
3Neoplasm Metastasis (Metastasis)
02/2021 - 01/2012
3Wounds and Injuries (Trauma)
01/2021 - 01/2010
3Bacterial Infections (Bacterial Infection)
12/2020 - 09/2003
3Multiple Myeloma
01/2020 - 06/2014
3Liver Cirrhosis (Hepatic Cirrhosis)
08/2018 - 01/2016
3Crohn Disease (Crohn's Disease)
03/2016 - 05/2008
2Neuroendocrine Tumors (Neuroendocrine Tumor)
04/2024 - 01/2023
2Endometriosis
04/2024 - 11/2023
2Cardiotoxicity
03/2024 - 03/2022
2Stroke (Strokes)
01/2024 - 10/2020
2Nasopharyngeal Carcinoma
11/2023 - 11/2020
2Cicatrix (Scar)
11/2023 - 11/2022
2Nervous System Diseases (Neurological Disorders)
11/2023 - 11/2021
2Thrombosis (Thrombus)
11/2023 - 03/2019
2Insulin Resistance
06/2023 - 03/2022

Drug/Important Bio-Agent (IBA)

26Proteins (Proteins, Gene)FDA Link
12/2023 - 03/2004
12Biomarkers (Surrogate Marker)IBA
01/2024 - 04/2008
10Doxorubicin (Adriamycin)FDA LinkGeneric
03/2024 - 01/2013
10LipidsIBA
02/2024 - 08/2015
10Messenger RNA (mRNA)IBA
01/2023 - 10/2003
9HMGN2 Protein (HMGN2)IBA
12/2019 - 01/2008
8Therapeutic UsesIBA
05/2024 - 01/2018
8Adenosine Triphosphate (ATP)IBA
11/2021 - 02/2005
7MicroRNAs (MicroRNA)IBA
01/2024 - 05/2015
7MicellesIBA
06/2021 - 01/2012
6RNA (Ribonucleic Acid)IBA
04/2024 - 01/2017
5Peptides (Polypeptides)IBA
12/2023 - 10/2003
5Glucose (Dextrose)FDA LinkGeneric
11/2023 - 03/2022
5Iodine-125IBA
11/2023 - 11/2017
4Indicators and Reagents (Reagents)IBA
02/2024 - 01/2017
4Anti-Bacterial Agents (Antibiotics)IBA
07/2023 - 10/2003
4beta-DefensinsIBA
07/2006 - 04/2003
3ProdrugsIBA
03/2024 - 09/2014
3Protein Kinases (Protein Kinase)IBA
11/2023 - 10/2017
3EnzymesIBA
10/2023 - 01/2017
3Sorafenib (BAY 43-9006)FDA Link
10/2023 - 04/2021
3CurcuminIBA
07/2023 - 11/2013
3Immune Checkpoint InhibitorsIBA
01/2023 - 01/2022
3CytokinesIBA
12/2022 - 01/2021
3Temozolomide (Temodar)FDA LinkGeneric
03/2022 - 10/2017
3AntioxidantsIBA
01/2022 - 01/2017
3LuteolinIBA
06/2021 - 10/2014
3PolymersIBA
04/2021 - 11/2012
3Calgranulin BIBA
11/2020 - 11/2013
3Hemoglobins (Hemoglobin)IBA
03/2019 - 05/2008
3NGR peptideIBA
01/2019 - 11/2016
3Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
12/2018 - 10/2017
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2016 - 03/2004
3QuercetinIBA
01/2015 - 01/2012
3Mitochondrial Permeability Transition PoreIBA
10/2012 - 08/2008
2Transcription Factors (Transcription Factor)IBA
04/2024 - 01/2023
2AntibodiesIBA
04/2024 - 11/2010
2Lipoproteins (Lipoprotein)IBA
02/2024 - 12/2023
2oxidized low density lipoproteinIBA
02/2024 - 06/2023
2Apolipoproteins E (ApoE)IBA
02/2024 - 03/2022
2C-Reactive ProteinIBA
01/2024 - 01/2017
2ChemokinesIBA
12/2023 - 01/2023
2Peroxynitrous Acid (Peroxynitrite)IBA
12/2023 - 01/2020
2Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2023 - 09/2018
2ErbB Receptors (EGF Receptor)IBA
12/2023 - 01/2017
2IodineIBA
11/2023 - 06/2016
2GadoliniumIBA
11/2023 - 01/2021
2lenvatinibIBA
11/2023 - 01/2023
2Cytidine Triphosphate (CTP)IBA
09/2023 - 10/2020
2Insulin (Novolin)FDA Link
06/2023 - 03/2022

Therapy/Procedure

33Therapeutics
05/2024 - 11/2004
9Drug Therapy (Chemotherapy)
03/2024 - 01/2015
4Brachytherapy
11/2023 - 11/2017
4Chinese Traditional Medicine (Traditional Chinese Medicine)
03/2020 - 11/2015
4Intravenous Injections
01/2019 - 02/2005
3Radiotherapy
12/2023 - 02/2010
3Quantum Dots (Quantum Dot)
08/2018 - 01/2017
3Intravenous Administration
03/2013 - 01/2009
3Transplantation
03/2013 - 12/2003